Effects of Mycophenolate Mofetil on Blood CD4+CD25+ Tcell of Rats with Experimental Autoimmune Encephalomyelitis

ZHU Zheng-yu,XIE Zhao-hong,YOU Wei,BI Jian-zhong,WANG Ping
DOI: https://doi.org/10.3969/j.issn.1001-1978.2011.08.017
2011-01-01
Abstract:Aim To investigate the therapeutic effects of mycophenolate mofetil on blood CD4+ CD25+ T cell of rats with experimental autoimmune encephalomyelitis.Method Wistar rats were induced by guinea pig spinal cord homogenate and Complete Freund Adjuvant to establish EAE models,while control rats were induced by saline and Complete Freund Adjuvant.There were 25 EAE rats which were successfully made and survived.The rats were randomly divided into four groups: high dose of mycophenolate mofetil treatment group(30 mg·kg-1·d-1,n=6),low dose of mycophenolate mofetil treatment group(20 mg·kg-1·d-1,n=6),methylprednisolone treatment group(30 mg·kg-1·d-1,n=6),model group(n=7),control group(n=6).Medicine was administered for 14 days and the rats was assessed by Duckers score every day.After 14 days,the percentage of blood CD4+CD25+ T cells was observed by flow cytometry,the pathological changes of brain and spine cord were observed by Hematoxylin and eosin staining.Result The achievement ratio of EAE model was 0.721.Compared with control group,the pathological changes of EAE rats manifested the inflammatory cells infiltration around vessels with HE staining,Duckers score increased,the number of blood CD4+CD25+ T cells decreased obviously(P0.01);Compared with model group,after treated with mycophenolate mofetil and methylprednisolone respectively,the Duckers score of EAE rats decreased,the pathological changes lessened and the percentage of blood CD4+CD25+ T cells increased(P0.01),moreover,the therapeutic effect of high dose mycophenolate mofetil was superior to low dose mycophenolate mofetil and methylprednisolone(P0.01);there was no obvious difference of the therapeutic effect between low dose mycophenolate mofetil and methylprednisolone.Conclusion Mycophenolate mofetil may affect immune suppression by increasing the percentage of CD4+ CD25+ T cells.
What problem does this paper attempt to address?